Clear Trail Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.86M Buy
14,766
+2,862
+24% +$734K 0.59% 49
2026
Q2
$3M Buy
11,904
+2,560
+27% +$551K 0.46% 58
2026
Q1
$2.03M Buy
9,344
+3,488
+60% +$774K 0.34% 62
2025
Q4
$1.34M Buy
+5,856
New +$1.33M 0.31% 60

Other funds holding ABBV

Clear Trail Advisors's ABBV Position: Q3 2026 in Review

Clear Trail Advisors increased its AbbVie (ABBV) stake by 24% in Q3 2026, buying an estimated $734K and bringing the position to 14,766 shares worth $3.86M. The position accounts for 0.59% of the portfolio, ranked #49.

Clear Trail Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,276 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Clear Trail Advisors held 14,766 shares of AbbVie worth $3.86M as of Q3 2026.
  • Clear Trail Advisors bought 2,862 AbbVie shares in Q3 2026, an estimated $734K.
  • AbbVie made up 0.59% of Clear Trail Advisors's portfolio in Q3 2026, its #49 holding.
  • Clear Trail Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,276 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.